The Leukemia Research Foundation announces the recipients of the
2024-2026 New Investigator Research Grant
Program. Grants of $150K, over
a two-year period, have been awarded to nine new investigators
worldwide.
NORTHFIELD, Ill., Aug. 13,
2024 /PRNewswire-PRWeb/ -- The Leukemia Research
Foundation is pleased to announce the recipients of the 2024-2026
New Investigator Research Grant
Program. Grants of $150K, over
a two-year period, have been awarded to nine new investigators
worldwide.
"They are some of the best and brightest
young scientists in the field, selected from a highly competitive
pool of applicants." ~ Kevin
Radelet, executive director Leukemia Research
Foundation
This total investment of $1.35M is
in addition to currently funded leukemia research for the 2023-2025
period, as well as the hundreds of other previously funded
cutting-edge projects. Overall, the Leukemia Research Foundation
has funded more than 600 projects since its inception.
"We are excited about the fresh, new ideas and perspectives
these investigators bring to leukemia research," said Kevin Radelet, executive director. "They are
some of the best and brightest young scientists in the field,
selected from a highly competitive pool of applicants. Research is
the center of our mission, and by funding groundbreaking projects
across all types of leukemia, new treatments are being pioneered.
As those discoveries happen, each one is moving us closer to a
cure."
Innovative projects
The Leukemia Research Foundation's competitive, peer-reviewed
program funds innovative projects from early-career investigators
who propose research that can lead to scientific breakthroughs.
This year's research projects span a range of topics to advance
discoveries in:
- Cancer cell biology, including T cell leukemias
- Treatments, including immunotherapies
- Causes and risk factors, including those of myelodysplastic
syndrome (MDS), Richter transformation, and genetically based
therapy resistance
The New Investigator Research Grant recipients for 2024-2026 are
included below, and specific details about their background and
projects can be found on our website.
- Shruti Bhatt, PhD, Assistant
Professor - Emory University
- Franco Izzo, PhD, Assistant
Professor - Icahn School of Medicine at Mount Sinai
- Nadia Kershaw, D. Phil., Laboratory Head - Walter and Eliza
Hall Institute of Medical Research - Victoria, Australia
- Shan Lin, PhD, Principal
Investigator - Seattle Children's Hospital
- Ioanna Mosialou, PhD, Assistant Professor - Columbia University Medical Center
- Santhosh K. Pasupuleti, PhD,
Assistant Research Professor - Indiana
University
- Elisa ten Hacken, PhD, Assistant Professor - Weill Medical College of Cornell University
- Alejandro Villarino, PhD,
Assistant Professor - Sylvester Comprehensive Cancer
Center/University of Miami Health
Systems
- Eric Wang, PhD, Assistant
Professor - The Jackson Laboratory for Genomic Medicine
Peer-reviewed process
The Foundation is grateful to the 24 physician-scientists and
researchers from prominent medical institutions around the world
who participated in this year's grant review. The panel evaluated
the proposals using similar methodology to that used by the
National Institutes of Health (NIH). Led by Justin Kline, MD, professor of medicine,
University of Chicago Medicine, the
review process culminated in the recommendation of nine projects
for funding.
To learn more about the Leukemia Research Foundation's New
Investigator Research Grant Program
and the deadlines for the 2025 grant program, visit
leukemiarf.org/research.
About the Leukemia Research Foundation
The Leukemia Research Foundation, headquartered in Northfield, Illinois, is committed to funding
innovative leukemia research worldwide and supporting people
affected by leukemia. Since its founding in 1946, more than
$90M has been raised to pursue better
treatments and the ultimate cure for leukemia. As the nation's
largest nonprofit focused exclusively on funding leukemia research,
the Leukemia Research Foundation has invested millions in more than
600 research projects worldwide to accelerate the development of
new and better treatments.
Media Contact
Maureen Jones, Leukemia Research
Foundation, 1 847.919.6250, maureen@leukemiarf.org,
leukemiarf.org
Twitter
View original content to download
multimedia:https://www.prweb.com/releases/the-leukemia-research-foundation-announces-2024-2026-research-grant-recipients-302221328.html
SOURCE Leukemia Research Foundation